FDA Related
FDA Approves Second Nasal Spray To Combat Opioid Crisis
RiVive, a 3 mg naloxone hydrochloride nasal spray, has been given the go-ahead by the U.S. Food and Drug Administration for over-the-counter (OTC), nonprescription use in the treatment of known or suspected…
FDA Disapproves 6,500 Flavored E-cigarettes From Marketing
Ten companies that combined produce and market roughly 6,500 flavored e-liquid and e-cigarette products were given marketing denial orders by the U.S. Food and Drug…
Opvee Nasal Spray Approved By FDA To Reverse Opioid Overdose
Opvee, the first nalmefene hydrochloride nasal spray, was given the go-ahead by the U.S. Food and Drug Administration for the emergency treatment of known or suspected opioid…
FDA Orders Mail-Back Envelopes For Unused Opioids
The FDA stated that makers of opioid analgesics supplied in outpatient settings must make prepaid mail-back envelopes accessible to outpatient pharmacies and other dispensers as an…
FDA: CPAP Machines May Not Deliver The Right Treatment
More than 1,000 apparently fixed Philips DreamStation CPAP and BiPAP machines are being recalled owing to a serial number mismatch, which may…
FDA Announces New Labeling & Safety Warnings For Opioids
In response to complaints that patients' sensitivity to pain or level of discomfort increased when using immediate-release (IR) and extended-release/long-acting (ER/LA) opioids, the…
FDA Approves Amphastar's Nasal Spray To Fight Opioid Crisis
Amphastar Pharmaceuticals Inc announced that the FDA had cleared its nasal spray for the emergency treatment of known or suspected opioid overdose.
According to the FDA label,…
The federal court in Florida handling the multidistrict case over hearing loss caused by allegedly defective 3M combat earplugs has called the company's technique to evaluate hearing loss "problematic." The U.S. District Court encouraged both 3M and the
Federal regulators have issued an updated warning about the risk of squamous cell carcinoma from breast implants, as well as various lymphomas that may form in the…
